Recent machine-extracted executive movements from SEC 8-K Item 5.02 filings, source-linked. Every card cites the SEC source.
Showing 6801–6850 of 18417
On January 5, 2024, Jason Bonfigt submitted to the Board of Directors of Sunworks, Inc. (the “Company”) his resignation from his position as Chief Financial Officer of the Company, effective January 5, 2024.
Lubi Kutua, the Company’s current Chief Financial Officer, Treasurer and principal financial officer, will assume the duties of principal accounting officer effective January 6, 2024 until a replacement is appointed.
Charley Jemley’s planned departure from his current role as Chief Financial Officer.
Joshua Guenser will join the Company as Incoming Chief Financial Officer on or about February 19, 2024 in concert with Charley Jemley’s planned departure from his current role as Chief Financial Officer.
Mr. Mariani’s severance benefits in connection with his departure include a severance amount equal to 12 months of his current base compensation and COBRA benefits for 12 months after he ceased to be an employee of the Company on December 22, 2023 (the “Separation Date”).
The Board of Directors (the “Board”) of CVS Health appointed Thomas F. Cowhey to serve as CVS Health’s Executive Vice President and Chief Financial Officer, effective January 5, 2024.
On January 5, 2024, CVS Health also announced that Shawn M. Guertin, who, as previously disclosed, was on a personal leave of absence since October 13, 2023, will step down from his role as CVS Health’s Executive Vice President, Chief Financial Officer and President of Health Services due to family health reasons, effective immediately.
Kevin DeLeon has resigned as our Chief Executive Officer, President, and Principal Financial and Accounting Officer.
Christopher Headrick, James McGinley, Neil Goulden have been appointed to our Board (with Mr. Headrick appointed as the Chairman of the Board).
On July 31, 2023, Basanite, Inc. (the “Company”) entered into an engagement letter with Thomas Richmond to join our Company as acting Interim Chief Executive Officer and as an independent contractor until December 31, 2023. As the engagement letter has not been extended by the Company, Mr. Richmond’s services with Basanite have terminated and he is no longer affiliated with the Company.
Mr. Strang will be replacing Michael Pope, whose last day as an employee of the Company will be January 12, 2024.
On January 4, 2024, the Board of Directors (the “Board”) of the Company appointed Dale Strang, a current member of the Board, to serve as the Company’s interim Chief Executive Officer and principal executive officer, effective immediately.
On January 5, 2024, Twist Bioscience Corporation (the “Company”) announced the appointment of Adam Laponis as the Company’s Chief Financial Officer and principal financial officer, effective January 8, 2024.
As previously reported by the Company in its Form 8-K filed on August 4, 2023 (the “Prior 8-K”), upon commencement of employment by Mr. Laponis, James Thorburn will no longer serve as the Company’s Chief Financial Officer.
Prior to resigning, the Board appointed Andrew Cohen, Daniel Wainstein, Lewis Silberman and Paul Baron to fill the vacancies on the Board created by such resignations and appointed Andrew Cohen as Chief Executive Officer of the Company.
On August 28, 2023, Canoo Inc. (the “ Company ”) announced the appointment of Greg Ethridge as Chief Financial Officer of the Company, effective immediately.
George Courtot resigned as the Company’s Chief Financial Officer
Keith Jaffee resigned as the Company’s Chief Executive Officer
On January 2, 2024, Brent D. Berg notified Rare Element Resources Ltd. (the “Company”) of his decision to resign as the President and Chief Executive Officer of the Company, and as a director of the Company, in each case effective as of April 2, 2024.
Dr. Egholm, the President, Chief Executive Officer, Treasurer and Secretary of Merger Sub, was appointed to the officer positions of President, Chief Executive Officer, Treasurer and Secretary of SomaLogic, which are the only officer positions of SomaLogic immediately following the effective time of the Merger.
the Board appointed Mark Dow of Rock Creek as the Company’s Chief Executive Officer, Chief Financial Officer and Secretary effective as of January 1, 2024.
the Board of Directors of the Company (the “Board”) appointed Heather L. Mason, currently a member of the Board, to serve as the Company’s Interim Chief Executive Officer
Effective as of January 2, 2024, Daniel A. Peisert, President and Chief Executive Officer and a director of Assertio Holdings, Inc. (the “Company”) separated from service as President and Chief Executive Officer of the Company.
On January 1, 2024, Dimitar A. Karaivanov, the Company’s Executive Vice President and Chief Operating Officer (“COO”), was appointed as the Company’s and the Bank’s President and Chief Executive Officer.
Consistent with the previously announced succession plan, on December 31, 2023, Mark E. Tryniski, the President and Chief Executive Officer of Community Bank System, Inc. (the “Company”) and its wholly-owned subsidiary, Community Bank, N.A. (the “Bank”) retired as an executive officer of the Company and the Bank.
Concurrent with the effective date of Ms. Kubota’s resignation as Chief Financial Officer, Bret “BJ” Mendenhall will be appointed as the Company’s outsourced Chief Financial Officer
On January 3, 2024, Kristina Kubota informed Pacific Health Care Organization, Inc. (the “Company”) that she will be stepping down as the Company’s Chief Financial Officer and Secretary, effective on March 5, 2024.
On November 7, 2023, Computer Programs & Systems, Inc. (the “Company”) announced that Matthew J. Chambless will no longer serve as the Company’s Chief Financial Officer, Treasurer and Secretary, effective December 31, 2023.
Kimberly A. Kuryea, currently Senior Vice President, Human Resources and Administration, will transition to Senior Vice President and Chief Financial Officer, effective February 15, 2024.
On January 5, 2024, the Company also announced that Winston Kung, the Company’s current Chief Operating Officer (“ COO ”) and CFO, will transition from his role as COO and CFO, effective January 4, 2024.
On January 5, 2024, PMV Pharmaceuticals, Inc. (the “ Company ”) announced the appointment of Michael Carulli as Chief Financial Officer (“ CFO ”), principal financial officer and principal accounting officer of the Company
On January 3, 2024, Santosh Shanbhag submitted his resignation as Chief Financial Officer and Treasurer of Akili, Inc. (the “Company”), and as principal financial officer (“PFO”) and principal accounting officer (“PAO”) of the Company, in each case effective as of January 12, 2024
On January 5, 2024, Mid Penn Bancorp, Inc. (the “Company”) announced that the Company and Allison S. Johnson, the Company’s Senior Executive Vice President and Chief Financial Officer, mutually agreed that Ms. Johnson would leave the Company to pursue other opportunities, effective December 29, 2023.
to succeed the Company’s current CFO and Treasurer, David Lund.
the Trinity Capital Inc. (the “Company”) Board of Directors (the “Board”) unanimously elected Michael Testa as Chief Financial Officer (“CFO”) and Treasurer of the Company, effective immediately on January 5, 2024
replacing David Pross who, as previously disclosed, notified the Company that he was retiring.
appointed Sunny Bhandarkar as its Chief Executive Officer, effective immediately
On December 28, 2023, Michael D. Ryan, Steve Brotman, Scott Grimes, John Rice, Marcie Vu and Tracy R. Wolstencroft resigned as members of the Board, and Matt Krna and Sean O’Brien resigned from their respective positions of Chief Executive Officer and Chief Financial Officer of the Company.
On December 28, 2023, Michael D. Ryan, Steve Brotman, Scott Grimes, John Rice, Marcie Vu and Tracy R. Wolstencroft resigned as members of the Board, and Matt Krna and Sean O’Brien resigned from their respective positions of Chief Executive Officer and Chief Financial Officer of the Company.
On January 3, 2024, the Board appointed Kanishka Roy as President, Chief Executive Officer, Secretary and Treasurer of the Company.
On January 5, 2024, Hull Xu tendered his resignation, resigning from his position as Chief Financial Officer, including as principal financial officer and principal accounting officer, of Cepton, Inc. (the “ Company ”) to pursue other opportunities.
the board of directors of the Company (the “ Board ”) appointed Dong (Dennis) Chang, the Company’s current Sr. Vice President of Manufacturing, as Interim Chief Financial Officer, including as principal financial officer and principal accounting officer, effective as of January 5, 2024.
On January 4, 2024, Nicolaus Radford, the Company’s Chief Executive Officer, departed the Company.
On January 4, 2024, the Board appointed John W. Gibson, Jr. as the Interim Chief Executive Officer and President of the Company, and designated Mr. Gibson as the “principal executive officer.”
the Board appointed Susan Kennedy as Chief Executive Officer of the Company effective as of January 1, 2024.
Scott Slater submitted his resignation on December 31, 2023, as Chief Executive Officer, President and a director of the Company effective as of such date.
On January 5, 2024 (the “Termination Date”), Chris DeAlmeida’s employment as Chief Financial Officer of Wrap Technologies, Inc. (the “Company”) was terminated without cause, effective immediately, pursuant to a Separation Agreement and Mutual Release of Claims (the “Separation Agreement”).
the Company appointed Christopher Whitaker, 52, as the Chief Financial Officer of the Company, effective January 1, 2024.
On December 31, 2023, Jerry Wenzel retired from employment with SOBR Safe, Inc. (the “ Company ”).
The Board of Directors (the “Board”) of the Company approved, effective as of January 3, 2024, the appointment of Richard Perez, the current Corporate Controller, as Chief Financial Officer of the Company.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.